PCUR-101
- Generic Name
- PCUR-101
Study of PCUR-101 in Combination With ADT in Patients With mCRPC
Phase 1
Terminated
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Pellficure Pharmaceuticals, Inc
- Target Recruit Count
- 7
- Registration Number
- NCT04677855
- Locations
- 🇺🇸
Nebraska Cancer Specialist, Omaha, Nebraska, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇦🇺St. George Private Hospital, Kogarah, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath